No abstract available
MeSH terms
-
Angiogenesis Inhibitors / pharmacology
-
Angiogenesis Inhibitors / therapeutic use
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Bevacizumab / pharmacology
-
Bevacizumab / therapeutic use
-
Clinical Trials as Topic
-
Drug Discovery
-
Female
-
Humans
-
Immunotherapy
-
Molecular Targeted Therapy
-
Mutation
-
Ovarian Neoplasms / drug therapy*
-
Ovarian Neoplasms / genetics
-
Ovarian Neoplasms / mortality
-
Ovarian Neoplasms / pathology
-
Prognosis
-
Research
-
Treatment Outcome
Substances
-
Angiogenesis Inhibitors
-
Antineoplastic Agents
-
Bevacizumab